Fundraising Fox

Synfini

3 known investors

Synfini operates an AI-driven "Agile Chemistry Foundry" that combines a dry lab with a robotic wet lab to accelerate design-make-test-analyze (DMTA) cycles for small-molecule drug discovery. It offers cloud-based access to AI models and laboratory automation for pharmaceutical researchers and drug hunters, from target selection through lead optimization.

AI & Machine LearningBiotechRobotics

Investors · 3

Foothill VenturesLos Altos · $100K – $10M
JSL Health CapitalreportedSarasota
WERU Investment Co. Ltd.reportedTokyo

In the news

As Nvidia hits $4T market cap, when does the AI investment frenzy peak? - SiliconANGLEsiliconangle.com · Jul 2025Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Developmentfinance.yahoo.com · Jul 2025Synfini gets $8.9M to accelerate drug discovery with AI - SiliconANGLEsiliconangle.com · Jul 2025Synfini Raises $8.9M in Expansion Fundingfinsmes.com · Jul 2025Synfini Stock for Accredited Investors | Pre-IPO Shares | UpMarketupmarket.co · Sep 2024Synfini, Inc. Spins Out of SRI International to Bring Novel Molecular Discovery Platform to Marketfinance.yahoo.com · Sep 2023

Frequently asked questions

What does Synfini do?
Synfini operates an AI-driven "Agile Chemistry Foundry" that combines a dry lab with a robotic wet lab to accelerate design-make-test-analyze (DMTA) cycles for small-molecule drug discovery. It offers cloud-based access to AI models and laboratory automation for pharmaceutical researchers and drug hunters, from target selection through lead optimization.
Who are Synfini's investors?
Synfini's investors include Foothill Ventures, JSL Health Capital, WERU Investment Co. Ltd..